SI1357910T1 - - Google Patents

Info

Publication number
SI1357910T1
SI1357910T1 SI200230115T SI200230115T SI1357910T1 SI 1357910 T1 SI1357910 T1 SI 1357910T1 SI 200230115 T SI200230115 T SI 200230115T SI 200230115 T SI200230115 T SI 200230115T SI 1357910 T1 SI1357910 T1 SI 1357910T1
Authority
SI
Slovenia
Application number
SI200230115T
Inventor
Maria Chovet
Laurent Diop
Original Assignee
Warner Lambert Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Warner Lambert Co filed Critical Warner Lambert Co
Publication of SI1357910T1 publication Critical patent/SI1357910T1/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/195Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/195Carboxylic acids, e.g. valproic acid having an amino group
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/06Anti-spasmodics, e.g. drugs for colics, esophagic dyskinesia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Nutrition Science (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
SI200230115T 2001-01-26 2002-01-25 SI1357910T1 (xx)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP01400214A EP1226820A1 (en) 2001-01-26 2001-01-26 Use of bicyclic amino acids for preventing and treating visceral pain and gastrointestinal disorders
PCT/EP2002/001351 WO2002058680A2 (en) 2001-01-26 2002-01-25 Use of bicylic amino acids for preventing and treating visceral pain and gastrointestinal disorders
EP02700218A EP1357910B1 (en) 2001-01-26 2002-01-25 Method for preventing and treating visceral pain and gastrointestinal disorders

Publications (1)

Publication Number Publication Date
SI1357910T1 true SI1357910T1 (xx) 2005-08-31

Family

ID=8182608

Family Applications (1)

Application Number Title Priority Date Filing Date
SI200230115T SI1357910T1 (xx) 2001-01-26 2002-01-25

Country Status (22)

Country Link
US (2) US6784208B2 (xx)
EP (3) EP1226820A1 (xx)
JP (2) JP2004517147A (xx)
KR (1) KR20030070140A (xx)
CN (1) CN1610544A (xx)
AR (1) AR036009A1 (xx)
AT (1) ATE293968T1 (xx)
BR (1) BR0206687A (xx)
CA (1) CA2435950A1 (xx)
DE (1) DE60203878T2 (xx)
DK (1) DK1357910T3 (xx)
ES (1) ES2240686T3 (xx)
IL (2) IL156667A0 (xx)
MX (1) MXPA03006723A (xx)
NZ (1) NZ526625A (xx)
PE (1) PE20020832A1 (xx)
PL (1) PL363354A1 (xx)
PT (1) PT1357910E (xx)
SI (1) SI1357910T1 (xx)
TW (1) TWI223593B (xx)
WO (1) WO2002058680A2 (xx)
ZA (2) ZA200305590B (xx)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1379494B1 (en) * 2001-04-19 2010-03-10 Warner-Lambert Company LLC Fused bicyclic or tricyclic amino acids
US7186855B2 (en) 2001-06-11 2007-03-06 Xenoport, Inc. Prodrugs of GABA analogs, compositions and uses thereof
US6818787B2 (en) 2001-06-11 2004-11-16 Xenoport, Inc. Prodrugs of GABA analogs, compositions and uses thereof
US8048917B2 (en) 2005-04-06 2011-11-01 Xenoport, Inc. Prodrugs of GABA analogs, compositions and uses thereof
US7232924B2 (en) 2001-06-11 2007-06-19 Xenoport, Inc. Methods for synthesis of acyloxyalkyl derivatives of GABA analogs
US7018818B2 (en) 2002-10-04 2006-03-28 Pfizer Inc. Intermediates in the preparation of therapeutic fused bicyclic amino acids
GB0223072D0 (en) 2002-10-04 2002-11-13 Pfizer Ltd Cyclic nitromethyl acetic acid derivatives
WO2006056874A1 (en) * 2004-11-25 2006-06-01 Pfizer Limited Salt form

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999008670A1 (en) * 1997-08-20 1999-02-25 Guglietta, Antonio Gaba analogs to prevent and treat gastrointestinal damage
KR100589066B1 (ko) * 1997-10-27 2006-06-13 워너-램버트 캄파니 엘엘씨 약제로서 유용한 시클릭 아미노산 및 그의 유도체
EP1031350A1 (en) * 1999-02-23 2000-08-30 Warner-Lambert Company Use of a gabapentin-analog for the manufacture of a medicament for preventing and treating visceral pain
HN2000000224A (es) * 1999-10-20 2001-04-11 Warner Lambert Co Aminoacidos biciclicos como agentes farmaceuticos
EP1379494B1 (en) * 2001-04-19 2010-03-10 Warner-Lambert Company LLC Fused bicyclic or tricyclic amino acids

Also Published As

Publication number Publication date
PT1357910E (pt) 2005-08-31
EP1514541A1 (en) 2005-03-16
US6784208B2 (en) 2004-08-31
WO2002058680A3 (en) 2002-09-19
DE60203878D1 (de) 2005-06-02
DK1357910T3 (da) 2005-08-08
US20040266876A1 (en) 2004-12-30
KR20030070140A (ko) 2003-08-27
NZ526625A (en) 2004-12-24
ATE293968T1 (de) 2005-05-15
AR036009A1 (es) 2004-08-04
ZA200407412B (en) 2005-06-29
ZA200305590B (en) 2004-10-18
JP2005015492A (ja) 2005-01-20
ES2240686T3 (es) 2005-10-16
EP1226820A1 (en) 2002-07-31
TWI223593B (en) 2004-11-11
CN1610544A (zh) 2005-04-27
MXPA03006723A (es) 2003-10-24
BR0206687A (pt) 2004-02-03
PE20020832A1 (es) 2002-10-03
WO2002058680A2 (en) 2002-08-01
IL156667A0 (en) 2004-01-04
US20020161047A1 (en) 2002-10-31
IL164012A0 (en) 2005-12-18
CA2435950A1 (en) 2002-08-01
EP1357910A2 (en) 2003-11-05
EP1357910B1 (en) 2005-04-27
JP2004517147A (ja) 2004-06-10
DE60203878T2 (de) 2006-02-16
PL363354A1 (en) 2004-11-15

Similar Documents

Publication Publication Date Title
BE2022C531I2 (xx)
BE2022C502I2 (xx)
BE2022C547I2 (xx)
BE2017C057I2 (xx)
BE2017C051I2 (xx)
BE2017C032I2 (xx)
BE2015C046I2 (xx)
BE2014C052I2 (xx)
BE2014C036I2 (xx)
BE2014C026I2 (xx)
BE2014C004I2 (xx)
BE2014C006I2 (xx)
BE2017C050I2 (xx)
BE2011C034I2 (xx)
BE2007C047I2 (xx)
AU2002307149A8 (xx)
HU0202991D0 (xx)
BRPI0209186B1 (xx)
BE2014C008I2 (xx)
CH1379220H1 (xx)
BRPI0204884B1 (xx)
BE2016C021I2 (xx)
BE2017C059I2 (xx)
BRPI0101486B8 (xx)
BE2012C051I2 (xx)